Cardiff Oncology Inc. buy melinda
Start price
05.04.19
/
50%
€3.84
Target price
04.11.21
€7.00
Performance (%)
29.61%
End price
05.11.21
€4.98
Summary
This prediction ended on 05.11.21 with a price of €4.98. The prediction had a final performance of 29.61%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cardiff Oncology Inc. | 14.725% | 14.725% | 283.260% | -38.225% |
iShares Core DAX® | 2.149% | 5.415% | 21.385% | 22.595% |
iShares Nasdaq 100 | 0.838% | 1.926% | 44.386% | 55.330% |
iShares Nikkei 225® | 1.143% | 2.887% | 27.641% | 9.481% |
iShares S&P 500 | 1.265% | 3.698% | 33.327% | 49.646% |
Comments by melinda for this prediction
In the thread Trovagene diskutieren
Biopharma
* TrovaGene gibt Vereinbarung mit einem globalen biopharmazeutischen Unternehmen , die Tests und Dienstleistungen zu verwenden trova® ctDNS in der klinischen Krebsstudien
Kursziel geändert auf 7,0
In the thread Trading Trovagene
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Cardiff Oncology Inc.
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.61
18.01.23
18.01.23
€2.00
18.01.24
18.01.24
-16.30%
19.01.24
19.01.24
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€76.61
22.06.17
22.06.17
€108.00
19.12.17
19.12.17
-82.61%
19.12.17
19.12.17
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€76.61
22.06.17
22.06.17
€108.00
19.12.17
19.12.17
-82.61%
19.12.17
19.12.17
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€271.44
05.05.16
05.05.16
€324.00
19.05.16
19.05.16
31.03%
19.05.16
19.05.16